(Q39392420)

English

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven). (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

0 references

author name string

G Kenet

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A Lubetsky

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

J Luboshitz

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

U Martinowitz

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

450-455

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Clinical use of recombinant FVIIa (rFVIIa).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Pharmacokinetics of recombinant activated factor VII (rFVIIa).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring, and cost effectiveness

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00059.X

21 January 2018

Identifiers

10.1046/J.1538-7836.2003.00059.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39392420&oldid=1970252259"